Skip to content

Calculus invests £2.4m in latest Scancell fundraising

Private equity fund manager and Enterprise Investment Scheme specialist Calculus Capital has invested £2.4m in a new fundraising by AIM-listed portfolio company Scancell Holdings plc. Calculus’s latest funding contributed to a total of £6.2m raised this month by Scancell. Scancell develops therapeutic immunotherapy vaccine platforms for the treatment of cancers and the funding will be used … Continued

Calculus Capital invests in Duvas Technologies

Private equity fund manager and Enterprise Investment Scheme specialist Calculus Capital has invested £2.25m in an Imperial College spin-out that has developed emissions detection technologies used to monitor air pollution in major cities and industrial centres around the world. Duvas Technologies (“Duvas”) produces equipment that enables remote sensing and identification of airborne chemicals and gases … Continued